- Alternative Medicine
- Mesothelioma Cure
- Mesothelioma Research
- Mesothelioma Doctors
- Mesothelioma Cancer Centers
- Mesothelioma Clinical Trials
Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Masonic Cancer Center
Contact Information
- 424 Harvard Street S.E. Minneapolis, MN 55455
- (612) 625-5411
Affiliated Doctors
The Masonic Cancer Center at the University of Minnesota is an important research and care facility that is included in the University’s Academic Health Center. Other care programs focus on medical, dental, public health, nursing and veterinary medicine. The Cancer Center has a mission of advancing knowledge and enhancing care for those who have cancer. The Center is located on the campus in Minneapolis.
As an NCI designated Comprehensive Cancer Center, their research programs are targeted to include basic, clinical and population studies. A major portion of the cancer center's programs involve research on tobacco related cancers and lung carcinogenesis. To achieve their goals, the center partners up with other research programs that study genetics, stem cells, immunology and tobacco use. Persons who have lung cancer, asbestosis or mesothelioma are well advised to take a look at these programs when seeking help for their diseases.
Holding the distinctive title of National Cancer Institute Comprehensive Cancer Center is an honor restricted to only the best institutions involved in cancer research, treatment and education. As one of only 40 institutions so honored, the Masonic Cancer Center is actively making significant advances in the research, treatment and education areas of cancer studies.
Technological advances are essential to developing new approaches that enhance detection and treatment of cancer. The center works with many clinical research partners and programs are available for interested persons who would like to participate in these clinical trials. Members of the Cancer Center have obtained research grants in excess of $70 million annually.
The U-M Masonic Cancer Center members are top cancer researchers. Over 500 faculty and staff are studying all aspects of cancer including bone marrow transplantation and pediatric oncology. The world’s first Burkitt’s lymphoma bone marrow transplant was performed here, and the center is home to leading edge research studies on umbilical cord blood transplantation, childhood cancer survivors and genetics. The relationship between cancer development and genetics, diet and family history is another area where this center is on the cutting edge of discovering cancer breakthroughs.
Some studies that are now in process include basic, clinical and population studies about cancer, immunology, transplant biology, chemoprevention, genetics of cancer, and cancer progression. The Center is best known for their tobacco related cancer research and treatment for tobacco harm.
TTURC, the Transdisciplinary Tobacco Use Research Center, is designated by the federal government to aid in the advanced understanding of cancer and other problems derived from tobacco use. Studies here helped to prove that nicotine is addictive and that carcinogens in tobacco cause cancer.
As an NCI-comprehensive matrix center, the Masonic Cancer Center participates in 8 research programs. They are involved with 12 shared resource cores that target quality of life through improved methods of cancer prevention, detection and treatment. Another NCI requirement fulfilled here is the establishment and operation of community outreach programs. Public education and awareness about cancer is shared with the public.
Patient comfort is an important goal for this Cancer Center. They are conducting studies through experimental and clinical research that are focused on bone pain caused by cancer. This is just one segment of the attention devoted by this center towards alleviating pain and improving quality of life for cancer patients and their survivors. Discoveries are shared with research partners, scientists, scholars and the public.